Joel Iff

Joel Iff is an accomplished professional in health economics and market access, currently serving as Executive Director of Global Access, Value & Evidence at Sarepta Therapeutics since March 2018, after a progression from Senior Director of HEOR & market access. Joel's expertise extends to strategic leadership as a Steering Committee Company Representative for cTAP-duchenne from June 2020 to June 2024, where responsibilities included championing strategic initiatives and aligning diverse teams. Prior experience includes roles at Mapi Group, Johnson & Johnson, Synthes, and sanofi-aventis, highlighting a strong foundation in health economics and market access. Joel holds a Doctorate in Pharmaceutical Sciences from the University of Geneva and a Diploma in Health Economics from the University of York.